Retinal tumors, though rare, present significant challenges in diagnosis and treatment. These tumors can arise from various cell types within the retina and may be benign or malignant. Early detection is crucial for preserving vision and preventing metastasis. Advancements in imaging technologies such as optical coherence tomography (OCT) and fundus fluorescein angiography (FFA) have enhanced diagnostic accuracy. Treatment options include laser therapy, cryotherapy, radiation, and surgical interventions like enucleation or vitrectomy. Emerging therapies like targeted drug delivery and immunotherapy offer promising avenues for personalized treatment approaches. Collaborative efforts between ophthalmologists, oncologists, and researchers are essential to improve outcomes and quality of life for patients with retinal tumors.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States